Cargando…

Association of Novel Androgen Receptor Axis-Targeted Therapies With Diarrhea in Patients With Prostate Cancer: A Bayesian Network Analysis

OBJECTIVE: To perform a systematic review and network meta-analysis to characterize the effect of novel androgen receptor axis-target (ARAT) agents on diarrhea and constipation. METHODS: We searched the Pubmed, Web of Science, and ClinicalTrials.gov up to September 2021 for phase 3 randomized contro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, Xingyu, Xu, Hang, Wang, Sheng, Liao, Xinyang, Yi, Xianyanling, Jin, Kun, Lei, Haoran, Bai, Shengjiang, Qiu, Shi, Yang, Lu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818787/ https://www.ncbi.nlm.nih.gov/pubmed/35141248 http://dx.doi.org/10.3389/fmed.2021.800823

Ejemplares similares

Combined Treatment of Radiotherapy and Immunotherapy for Urological Malignancies: Current Evidence and Clinical Considerations
por: Lei, Haoran, et al.
Publicado: (2021)

Which Type of Exercise During Radiation Therapy Is Optimal to Improve Fatigue and Quality of Life in Men with Prostate Cancer? A Bayesian Network Analysis
por: Xiong, Xingyu, et al.
Publicado: (2022)

Biomarker-Based Targeting of the Androgen-Androgen Receptor Axis in Advanced Prostate Cancer
por: Kohli, Manish, et al.
Publicado: (2012)

Androgen receptor signaling and spatial chromatin organization in castration-resistant prostate cancer
por: Zhou, Tianyi, et al.
Publicado: (2022)

Androgen Receptor Signaling and the Emergence of Lethal Neuroendocrine Prostate Cancer With the Treatment-Induced Suppression of the Androgen Receptor: A Literature Review
por: Dhavale, Meera, et al.
Publicado: (2021)

SR9009 inhibits lethal prostate cancer subtype 1 by regulating the LXRα/FOXM1 pathway independently of REV-ERBs
por: Xu, Hang, et al.
Publicado: (2022)

Prostate Cancer Characteristics Associated with Response to Pre-Receptor Targeting of the Androgen Axis
por: Mostaghel, Elahe A., et al.
Publicado: (2014)

Androgen Receptor-CaMKK2 Axis in Prostate Cancer and Bone Microenvironment
por: Dadwal, Ushashi C., et al.
Publicado: (2018)

Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
por: Sharp, Adam, et al.
Publicado: (2018)

CXCL8 in Tumor Biology and Its Implications for Clinical Translation
por: Xiong, Xingyu, et al.
Publicado: (2022)

Therapies Targeted to Androgen Receptor Signaling Axis in Prostate Cancer: Progress, Challenges, and Hope
por: Saranyutanon, Sirin, et al.
Publicado: (2019)

The effect of different administrations of testosterone therapy on adverse prostate events: A Bayesian network meta-analysis
por: Zeng, Bin, et al.
Publicado: (2022)

The androgen receptor—lncRNASAT1-AKT-p15 axis mediates androgen-induced cellular senescence in prostate cancer cells
por: Mirzakhani, Kimia, et al.
Publicado: (2021)

11-Ketotestosterone is the predominant active androgen in prostate cancer patients after castration
por: Snaterse, Gido, et al.
Publicado: (2021)

Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy
por: Yi, Xianyanling, et al.
Publicado: (2023)

Androgen receptor-mediated upregulation of quaking affects androgen receptor-related prostate cancer development and anti-androgen receptor therapy
por: Zhang, Keke, et al.
Publicado: (2018)

Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccine
por: Zheng, Xiaonan, et al.
Publicado: (2021)

Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer
por: Koochekpour, Shahriar
Publicado: (2014)

Role of androgen receptor splice variants in prostate cancer metastasis
por: Xu, Jin, et al.
Publicado: (2016)

Correction to: The androgen receptor—lncRNASAT1-AKT-p15 axis mediates androgen-induced cellular senescence in prostate cancer cells
por: Mirzakhani, Kimia, et al.
Publicado: (2021)

Novel Strategy of Proxalutamide for the Treatment of Prostate Cancer through Coordinated Blockade of Lipogenesis and Androgen Receptor Axis
por: Gu, Yue, et al.
Publicado: (2021)

Androgen receptor axis-targeted agents are not superior to conventional hormonal therapy for treatment of metastatic prostate cancer
por: Wada, Akinori, et al.
Publicado: (2022)

Optimization of anesthetic decision-making in ERAS using Bayesian network
por: Chen, Yuwen, et al.
Publicado: (2022)

Diarrhea or No Diarrhea, It Still Hurts: An Atypical Case of Clostridioides difficile
por: Singla, Abhinav, et al.
Publicado: (2020)

Plasma Androgen Receptor in Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2019)

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
por: Chuu, Chih-Pin, et al.
Publicado: (2011)

The Androgen Receptor and VEGF: Mechanisms of Androgen-Regulated Angiogenesis in Prostate Cancer
por: Eisermann, Kurtis, et al.
Publicado: (2017)

Response to Androgens and Androgen Receptor Antagonists in the Presence of Cytokines in Prostate Cancer
por: Culig, Zoran
Publicado: (2021)

Small-Molecule Inhibition of Androgen Receptor Dimerization as a Strategy against Prostate Cancer
por: Fu, Weitao, et al.
Publicado: (2023)

Selective Androgen Receptor Modulator Induced Hepatotoxicity
por: Khan, Sohaib, et al.
Publicado: (2022)

Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer
por: Sowalsky, Adam G., et al.
Publicado: (2022)

CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer
por: Hwang, Justin H., et al.
Publicado: (2019)

Androgen Receptor Pathway Activity Assay for Sepsis Diagnosis and Prediction of Favorable Prognosis
por: Bouwman, Wilbert, et al.
Publicado: (2021)

Castration-Resistant Prostate Cancer Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents: Opportunities and Challenges
por: Kita, Yuki, et al.
Publicado: (2018)

LINC00675 activates androgen receptor axis signaling pathway to promote castration-resistant prostate cancer progression
por: Yao, Mengfei, et al.
Publicado: (2020)

A GATA2-CDC6 axis modulates androgen receptor blockade-induced senescence in prostate cancer
por: Mourkioti, Ioanna, et al.
Publicado: (2023)

Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells.
por: Sherwood, E. R., et al.
Publicado: (1998)

Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer
por: Wen, Simeng, et al.
Publicado: (2020)

Metabolic Roles of Androgen Receptor and Tip60 in Androgen-Dependent Prostate Cancer
por: Tan, Kah Ni, et al.
Publicado: (2020)

Comparison of the Efficacy and Safety of Extracorporeal Shock Wave Lithotripsy and Flexible Ureteroscopy for Treatment of Urolithiasis in Horseshoe Kidney Patients: A Systematic Review and Meta-Analysis
por: Yi, Xianyanling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s5ljo1qph94407agnup1sc7fv1